Filter
1440
Filtered Results: 1440
Text search:
adverse
drug
event
Featured
Recommendations
182
New Publications
348
Language
Document type
No document type
790
Guidelines
285
Studies & Reports
177
Manuals
94
Strategic & Response Plan
45
Fact sheets
20
Training Material
16
Situation Updates
6
Infographics
3
Brochures
1
App
1
Resource Platforms
1
Online Courses
1
Countries / Regions
India
94
Global
47
Western and Central Europe
40
South Africa
34
Ethiopia
31
Kenya
29
Nigeria
24
Ghana
23
Latin America and the Carribbean
23
Bangladesh
19
Uganda
18
Eastern Europe
18
Nepal
15
Africa
15
Tanzania
15
Namibia
13
Sierra Leone
12
Philippines
12
South–East Asia Region
12
Liberia
11
Myanmar / Burma
11
Zimbabwe
9
Cambodia
9
Zambia
9
Rwanda
8
Malawi
8
Colombia
7
USA
7
Asia
7
Eastern Europe and Central Asia
7
Syria
6
Argentina
6
Brazil
6
Ukraine
5
Mozambique
5
Western Pacific Region
5
East and Southern Africa
5
Botswana
5
Indonesia
5
West and Central Africa
4
Eswatini/ Swaziland
4
Timor Leste/ East Timor
3
Thailand
3
Lesotho
3
Germany
3
Middle East and North Africa
3
South Sudan
3
North Macedonia
2
Tajikistan
2
China
2
Chile
2
Laos
2
Congo, Democratic Republic of
2
Paraguay
2
United Kingdom
2
Bolivia
2
Vietnam
2
Georgia
2
Angola
2
Bhutan
2
North Korea
1
Australia
1
Kazakhstan
1
Cameroon
1
Albania
1
Fiji
1
Senegal
1
Kyrgyzstan
1
Bulgaria
1
Guinea
1
Haiti
1
Guinea-Bissau
1
Ireland
1
North America
1
Belarus
1
Lebanon
1
Sri Lanka
1
Russia
1
Mali
1
Chad
1
Iraq
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
455
Clinical Guidelines
225
Public Health
88
Women & Child Health
73
Key Resources
46
Pharmacy & Technologies
26
Capacity Building
21
Toolboxes
TB
157
Mental Health
144
HIV
136
COVID-19
79
Pharmacy
73
NTDs
60
AMR
57
Rapid Response
37
NCDs
32
Caregiver
31
Malaria
28
Ebola & Marburg
23
Planetary Health
20
Refugee
18
Global Health Education
17
Specific Hazards
14
Conflict
13
Polio
11
Disability
9
Natural Hazards
6
Cholera
6
Zika
5
Health Financing Toolbox
4
Social Ethics
2
Towards the Peoples Health Assembly Book - 5
WHO recommendations on child health: Guidelines approved by the WHO Guidelines Review Committee
recommended
Updated May 2017
This document is meant to respond to the questions:
■ What health interventions should the child receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
This document is meant to respond to the questions:
■ What health interventions should the child receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
he WHO South-East Region in 2019 accounted for nearly a million missing TB patients from the estimated incidence. Active case-finding (ACF) or systematic screening for tuberculosis is an important tool to reach out to missing TB patients. When appropriately implemented, the activity is cost effectiv...
Training Workshop
Standard Treatment Guideline
The Quadripartite Organizations – the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP), the World Organisation for Animal Health (WOAH, founded as OIE), and the World Health Organization (WHO) – collaborate to drive the change and tra...
The objective of the EMTCT Plus initiative is to achieve and sustain the elimination
of mother-to-child transmission of HIV, syphilis, Chagas, and perinatal hepatitis
B (HBV) as a public health threat. It embraces the principles and lines of action
of the Strategy for Universal Access to Health a...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and analysing the extent to which selected international...
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...
Global Tuberculosis Report 2021
recommended
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The...
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
This publication gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and control, and highlights the neners. This new guide updates the 2006 edition...
Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Integrated control and management of skin NTDs offers ...
